{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T14:33:31Z","timestamp":1782398011418,"version":"3.54.5"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Spanish Cell Therapy Network-Instituto de Salud Carlos III","award":["RETICS RD16\/0011\/0032"],"award-info":[{"award-number":["RETICS RD16\/0011\/0032"]}]},{"name":"Spanish Ministry of Economy and Competitiveness","award":["SAF 2014-56101-R"],"award-info":[{"award-number":["SAF 2014-56101-R"]}]},{"DOI":"10.13039\/501100004837","name":"Spanish Ministry of Science and Innovation","doi-asserted-by":"crossref","award":["PID2020-118189RB-I00"],"award-info":[{"award-number":["PID2020-118189RB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-024-03965-0","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T18:02:02Z","timestamp":1728496922000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The therapeutic use of clonal neural stem cells in experimental Parkinson\u00b4s disease"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7281-5944","authenticated-orcid":false,"given":"Anna","family":"Nelke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Garc\u00eda-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier R.","family":"Caso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta P.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,9]]},"reference":[{"issue":"10","key":"3965_CR1","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.autrev.2016.07.022","volume":"15","author":"A De Virgilio","year":"2016","unstructured":"De Virgilio A, Greco A, Fabbrini G, Inghilleri M, Rizzo MI, Gallo A, et al. Parkinson\u2019s disease: autoimmunity and neuroinflammation. Autoimmun Rev. 2016;15(10):1005\u201311.","journal-title":"Autoimmun Rev"},{"issue":"9996","key":"3965_CR2","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE. Parkinson\u2019s disease. Lancet. 2015;386(9996):896\u2013912.","journal-title":"Lancet"},{"issue":"R1","key":"3965_CR3","doi-asserted-by":"publisher","first-page":"R48","DOI":"10.1093\/hmg\/ddp012","volume":"18","author":"S Lesage","year":"2009","unstructured":"Lesage S, Brice A. Parkinson\u2019s disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet. 2009;18(R1):R48\u201359.","journal-title":"Hum Mol Genet"},{"issue":"Suppl 1","key":"3965_CR4","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1007\/s10654-011-9581-6","volume":"26","author":"K Wirdefeldt","year":"2011","unstructured":"Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J. Epidemiology and etiology of Parkinson\u2019s disease: a review of the evidence. Eur J Epidemiol. 2011;26(Suppl 1):S1\u201358.","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"3965_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.pharmthera.2013.01.004","volume":"138","author":"SJ Allen","year":"2013","unstructured":"Allen SJ, Watson JJ, Shoemark DK, Barua NU, Patel NK. GDNF, NGF and BDNF as therapeutic options for neurodegeneration. Pharmacol Ther. 2013;138(2):155\u201375.","journal-title":"Pharmacol Ther"},{"issue":"4","key":"3965_CR6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0891-0618(01)00115-6","volume":"21","author":"NB Chauhan","year":"2001","unstructured":"Chauhan NB, Siegel GJ, Lee JM. Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson\u2019s disease brain. J Chem Neuroanat. 2001;21(4):277\u201388.","journal-title":"J Chem Neuroanat"},{"key":"3965_CR7","doi-asserted-by":"publisher","unstructured":"Sarkar S, Raymick J, Imam S. Neuroprotective and Therapeutic Strategies against Parkinson\u2019s Disease: Recent Perspectives. Int J Mol Sci. 2016;17(6). https:\/\/doi.org\/10.3390\/ijms17060904.","DOI":"10.3390\/ijms17060904"},{"issue":"2","key":"3965_CR8","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1006\/mcne.2002.1171","volume":"21","author":"P Akerud","year":"2002","unstructured":"Akerud P, Holm PC, Castelo-Branco G, Sousa K, Rodriguez FJ, Arenas E. Persephin-overexpressing neural stem cells regulate the function of nigral dopaminergic neurons and prevent their degeneration in a model of Parkinson\u2019s disease. Mol Cell Neurosci. 2002;21(2):205\u201322.","journal-title":"Mol Cell Neurosci"},{"issue":"4","key":"3965_CR9","doi-asserted-by":"publisher","first-page":"549","DOI":"10.4103\/1673-5374.205084","volume":"12","author":"TB Sampaio","year":"2017","unstructured":"Sampaio TB, Savall AS, Gutierrez MEZ, Pinton S. Neurotrophic factors in Alzheimer\u2019s and Parkinson\u2019s diseases: implications for pathogenesis and therapy. Neural Regen Res. 2017;12(4):549\u201357.","journal-title":"Neural Regen Res"},{"issue":"3","key":"3965_CR10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cytogfr.2011.05.001","volume":"22","author":"AM Sullivan","year":"2011","unstructured":"Sullivan AM, Toulouse A. Neurotrophic factors for the treatment of Parkinson\u2019s disease. Cytokine Growth Factor Rev. 2011;22(3):157\u201365.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"5","key":"3965_CR11","doi-asserted-by":"publisher","first-page":"809","DOI":"10.2174\/1381612822666161208120422","volume":"23","author":"D Tome","year":"2017","unstructured":"Tome D, Fonseca CP, Campos FL, Baltazar G. Role of neurotrophic factors in Parkinson\u2019s Disease. Curr Pharm Des. 2017;23(5):809\u201338.","journal-title":"Curr Pharm Des"},{"issue":"2","key":"3965_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00005-015-0376-4","volume":"64","author":"N Xiao","year":"2016","unstructured":"Xiao N, Le QT. Neurotrophic factors and their potential applications in tissue regeneration. Arch Immunol Ther Exp (Warsz). 2016;64(2):89\u201399.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"3965_CR13","first-page":"4263795","volume":"2017","author":"B Caballero","year":"2017","unstructured":"Caballero B, Sherman SJ, Falk T. Insights into the mechanisms involved in Protective effects of VEGF-B in dopaminergic neurons. Parkinsons Dis. 2017;2017:4263795.","journal-title":"Parkinsons Dis"},{"issue":"42","key":"3965_CR14","doi-asserted-by":"publisher","first-page":"14592","DOI":"10.1523\/JNEUROSCI.0539-12.2012","volume":"32","author":"JM Morganti","year":"2012","unstructured":"Morganti JM, Nash KR, Grimmig BA, Ranjit S, Small B, Bickford PC, et al. The soluble isoform of CX3CL1 is necessary for neuroprotection in a mouse model of Parkinson\u2019s disease. J Neurosci. 2012;32(42):14592\u2013601.","journal-title":"J Neurosci"},{"issue":"1","key":"3965_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/mt.2014.175","volume":"23","author":"KR Nash","year":"2015","unstructured":"Nash KR, Moran P, Finneran DJ, Hudson C, Robinson J, Morgan D, et al. Fractalkine over expression suppresses alpha-synuclein-mediated neurodegeneration. Mol Ther. 2015;23(1):17\u201323.","journal-title":"Mol Ther"},{"key":"3965_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1742-2094-8-9","volume":"8","author":"MM Pabon","year":"2011","unstructured":"Pabon MM, Bachstetter AD, Hudson CE, Gemma C, Bickford PC. CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson\u2019s disease. J Neuroinflammation. 2011;8:9. -2094-8-9.","journal-title":"J Neuroinflammation"},{"key":"3965_CR17","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.neuroscience.2011.06.084","volume":"192","author":"M Piltonen","year":"2011","unstructured":"Piltonen M, Planken A, Leskela O, Myohanen TT, Hanninen AL, Auvinen P, et al. Vascular endothelial growth factor C acts as a neurotrophic factor for dopamine neurons in vitro and in vivo. Neuroscience. 2011;192:550\u201363.","journal-title":"Neuroscience"},{"issue":"3","key":"3965_CR18","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.neulet.2007.05.033","volume":"421","author":"YY Tian","year":"2007","unstructured":"Tian YY, Tang CJ, Wang JN, Feng Y, Chen XW, Wang L, et al. Favorable effects of VEGF gene transfer on a rat model of Parkinson disease using adeno-associated viral vectors. Neurosci Lett. 2007;421(3):239\u201344.","journal-title":"Neurosci Lett"},{"issue":"6","key":"3965_CR19","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1111\/j.1460-9568.2004.03254.x","volume":"19","author":"T Yasuhara","year":"2004","unstructured":"Yasuhara T, Shingo T, Kobayashi K, Takeuchi A, Yano A, Muraoka K, et al. Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson\u2019s disease. Eur J Neurosci. 2004;19(6):1494\u2013504.","journal-title":"Eur J Neurosci"},{"issue":"1\u20132","key":"3965_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.brainres.2005.05.027","volume":"1053","author":"T Yasuhara","year":"2005","unstructured":"Yasuhara T, Shingo T, Muraoka K, Kameda M, Agari T, Wen Ji Y, et al. Neurorescue effects of VEGF on a rat model of Parkinson\u2019s disease. Brain Res. 2005;1053(1\u20132):10\u20138.","journal-title":"Brain Res"},{"issue":"48","key":"3965_CR21","doi-asserted-by":"publisher","first-page":"12497","DOI":"10.1523\/JNEUROSCI.3719-06.2006","volume":"26","author":"T Yasuhara","year":"2006","unstructured":"Yasuhara T, Matsukawa N, Hara K, Yu G, Xu L, Maki M, et al. Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson\u2019s disease. J Neurosci. 2006;26(48):12497\u2013511.","journal-title":"J Neurosci"},{"issue":"2","key":"3965_CR22","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3727\/000000007783464632","volume":"16","author":"T Yasuhara","year":"2007","unstructured":"Yasuhara T, Date I. Intracerebral transplantation of genetically engineered cells for Parkinson\u2019s disease: toward clinical application. Cell Transpl. 2007;16(2):125\u201332.","journal-title":"Cell Transpl"},{"key":"3965_CR23","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3389\/fnins.2018.00693","volume":"12","author":"TB Stoker","year":"2018","unstructured":"Stoker TB, Torsney KM, Barker RA. Emerging treatment approaches for Parkinson\u2019s Disease. Front Neurosci. 2018;12:693.","journal-title":"Front Neurosci"},{"issue":"6","key":"3965_CR24","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/j.celrep.2014.05.027","volume":"7","author":"PJ Hallett","year":"2014","unstructured":"Hallett PJ, Cooper O, Sadi D, Robertson H, Mendez I, Isacson O. Long-term health of dopaminergic neuron transplants in Parkinson\u2019s disease patients. Cell Rep. 2014;7(6):1755\u201361.","journal-title":"Cell Rep"},{"issue":"23","key":"3965_CR25","doi-asserted-by":"publisher","first-page":"6544","DOI":"10.1073\/pnas.1605245113","volume":"113","author":"W Li","year":"2016","unstructured":"Li W, Englund E, Widner H, Mattsson B, van Westen D, Latt J, et al. Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain. Proc Natl Acad Sci U S A. 2016;113(23):6544\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"3965_CR26","doi-asserted-by":"publisher","first-page":"777","DOI":"10.2217\/rme-2016-0102","volume":"11","author":"TB Stoker","year":"2016","unstructured":"Stoker TB, Barker RA. Cell therapies for Parkinson\u2019s disease: how far have we come? Regen Med. 2016;11(8):777\u201386.","journal-title":"Regen Med"},{"key":"3965_CR27","unstructured":"U.S. National Library of Medicine. https:\/\/clinicaltrials.gov. (2023). Accessed 1 April 2023."},{"issue":"9","key":"3965_CR28","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1177\/0963689717735411","volume":"26","author":"T Yasuhara","year":"2017","unstructured":"Yasuhara T, Kameda M, Sasaki T, Tajiri N, Date I. Cell therapy for Parkinson\u2019s Disease. Cell Transpl. 2017;26(9):1551\u20139.","journal-title":"Cell Transpl"},{"issue":"12","key":"3965_CR29","doi-asserted-by":"publisher","first-page":"e52714","DOI":"10.1371\/journal.pone.0052714","volume":"7","author":"T Ramos-Moreno","year":"2012","unstructured":"Ramos-Moreno T, Lendinez JG, Pino-Barrio MJ, Del Arco A, Martinez-Serrano A. Clonal human fetal ventral mesencephalic dopaminergic neuron precursors for cell therapy research. PLoS ONE. 2012;7(12):e52714.","journal-title":"PLoS ONE"},{"key":"3965_CR30","doi-asserted-by":"publisher","first-page":"773925","DOI":"10.3389\/fphar.2021.773925","volume":"12","author":"A Nelke","year":"2022","unstructured":"Nelke A, Garc\u00eda-L\u00f3pez S, Mart\u00ednez-Serrano A, Pereira MP. Multifactoriality of Parkinson\u2019s disease as explored through human neural stem cells and their transplantation in Middle-aged parkinsonian mice. Front Pharmacol. 2022;12:773925.","journal-title":"Front Pharmacol"},{"issue":"11","key":"3965_CR31","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1016\/j.yexcr.2009.03.011","volume":"315","author":"A Villa","year":"2009","unstructured":"Villa A, Liste I, Courtois ET, Seiz EG, Ramos M, Meyer M, et al. Generation and properties of a new human ventral mesencephalic neural stem cell line. Exp Cell Res. 2009;315(11):1860\u201374.","journal-title":"Exp Cell Res"},{"issue":"41","key":"3965_CR32","doi-asserted-by":"publisher","first-page":"38884","DOI":"10.1074\/jbc.M205518200","volume":"277","author":"J Lotharius","year":"2002","unstructured":"Lotharius J, Barg S, Wiekop P, Lundberg C, Raymon HK, Brundin P. Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line. J Biol Chem. 2002;277(41):38884\u201394.","journal-title":"J Biol Chem"},{"issue":"1","key":"3965_CR33","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nprot.2006.342","volume":"2","author":"V Jackson-Lewis","year":"2007","unstructured":"Jackson-Lewis V, Przedborski S. Protocol for the MPTP mouse model of Parkinson\u2019s disease. Nat Protoc. 2007;2(1):141\u201351.","journal-title":"Nat Protoc"},{"issue":"7","key":"3965_CR34","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/embj.201386392","volume":"33","author":"L Formentini","year":"2014","unstructured":"Formentini L, Pereira MP, Sanchez-Cenizo L, Santacatterina F, Lucas JJ, Navarro C, et al. In vivo inhibition of the mitochondrial H+-ATP synthase in neurons promotes metabolic preconditioning. EMBO J. 2014;33(7):762\u201378.","journal-title":"EMBO J"},{"issue":"1\u20133","key":"3965_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","volume":"463","author":"L Prut","year":"2003","unstructured":"Prut L, Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol. 2003;463(1\u20133):3\u201333.","journal-title":"Eur J Pharmacol"},{"key":"3965_CR36","volume-title":"The mouse brain in stereotaxic coordinates","author":"G Paxinos","year":"2001","unstructured":"Paxinos G, Franklin KBJ. The mouse brain in stereotaxic coordinates. 2nd ed. San Diego: Academic; 2001.","edition":"2"},{"issue":"1","key":"3965_CR37","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1038\/s41598-017-01747-8","volume":"7","author":"BM Davis","year":"2017","unstructured":"Davis BM, Salinas-Navarro M, Cordeiro MF, Moons L, De Groef L. Characterizing microglia activation: a spatial statistics approach to maximize information extraction. Sci Rep. 2017;7(1):1576.","journal-title":"Sci Rep"},{"key":"3965_CR38","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.expneurol.2016.05.027","volume":"282","author":"A Heuer","year":"2016","unstructured":"Heuer A, Kirkeby A, Pfisterer U, J\u00f6nsson ME, Parmar M. hESC-derived neural progenitors prevent xenograft rejection through neonatal desensitisation. Exp Neurol. 2016;282:78\u201385.","journal-title":"Exp Neurol"},{"issue":"6","key":"3965_CR39","doi-asserted-by":"publisher","first-page":"e12410","DOI":"10.1111\/xen.12410","volume":"25","author":"J Villadiego","year":"2018","unstructured":"Villadiego J, Romo-Madero S, Garc\u00eda-Swinburn R, Su\u00e1rez-Luna N, Bermejo-Navas A, Echevarr\u00eda M, et al. Long-term immunosuppression for CNS mouse xenotransplantation: effects on nigrostriatal neurodegeneration and neuroprotective carotid body cell therapy. Xenotransplantation. 2018;25(6):e12410.","journal-title":"Xenotransplantation"},{"issue":"2\u20133","key":"3965_CR40","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0162-3109(00)00192-2","volume":"47","author":"S Matsuda","year":"2000","unstructured":"Matsuda S, Koyasu S. Mechanisms of action of cyclosporine. Immunopharmacology. 2000;47(2\u20133):119\u201325.","journal-title":"Immunopharmacology"},{"issue":"7","key":"3965_CR41","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1084\/jem.20142290","volume":"212","author":"A Aspelund","year":"2015","unstructured":"Aspelund A, Antila S, Proulx ST, Karlsen TV, Karaman S, Detmar M, et al. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J Exp Med. 2015;212(7):991\u20139.","journal-title":"J Exp Med"},{"key":"3965_CR42","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/srep01114","volume":"3","author":"J Huang","year":"2013","unstructured":"Huang J, Zhu C, Zhang P, Zhu Q, Liu Y, Zhu Z, et al. S100\u2009+\u2009cells: a new neuro-immune cross-talkers in lymph organs. Sci Rep. 2013;3:1114.","journal-title":"Sci Rep"},{"issue":"7560","key":"3965_CR43","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature14432","volume":"523","author":"A Louveau","year":"2015","unstructured":"Louveau A, Smirnov I, Keyes TJ, Eccles JD, Rouhani SJ, Peske JD, et al. Structural and functional features of central nervous system lymphatic vessels. Nature. 2015;523(7560):337\u201341.","journal-title":"Nature"},{"key":"3965_CR44","doi-asserted-by":"publisher","first-page":"16866","DOI":"10.1038\/srep16866","volume":"5","author":"C Wulfing","year":"2015","unstructured":"Wulfing C, Gunther HS. Dendritic cells and macrophages neurally hard-wired in the lymph node. Sci Rep. 2015;5:16866.","journal-title":"Sci Rep"},{"issue":"5","key":"3965_CR45","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1046\/j.1471-4159.2003.01931.x","volume":"86","author":"M Emgard","year":"2003","unstructured":"Emgard M, Hallin U, Karlsson J, Bahr BA, Brundin P, Blomgren K. Both apoptosis and necrosis occur early after intracerebral grafting of ventral mesencephalic tissue: a role for protease activation. J Neurochem. 2003;86(5):1223\u201332.","journal-title":"J Neurochem"},{"issue":"4","key":"3965_CR46","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.neuroscience.2004.11.048","volume":"131","author":"VF Rafuse","year":"2005","unstructured":"Rafuse VF, Soundararajan P, Leopold C, Robertson HA. Neuroprotective properties of cultured neural progenitor cells are associated with the production of sonic hedgehog. Neuroscience. 2005;131(4):899\u2013916.","journal-title":"Neuroscience"},{"issue":"3","key":"3965_CR47","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/1098-2396(20001201)38:3<363::AID-SYN16>3.0.CO;2-A","volume":"38","author":"E Bezard","year":"2000","unstructured":"Bezard E, Dovero S, Imbert C, Boraud T, Gross CE. Spontaneous long-term compensatory dopaminergic sprouting in MPTP-treated mice. Synapse. 2000;38(3):363\u20138.","journal-title":"Synapse"},{"issue":"15","key":"3965_CR48","doi-asserted-by":"publisher","first-page":"5614","DOI":"10.1523\/JNEUROSCI.18-15-05614.1998","volume":"18","author":"A Ho","year":"1998","unstructured":"Ho A, Blum M. Induction of interleukin-1 associated with compensatory dopaminergic sprouting in the denervated striatum of young mice: model of aging and neurodegenerative disease. J Neurosci. 1998;18(15):5614\u201329.","journal-title":"J Neurosci"},{"issue":"4","key":"3965_CR49","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/jnr.20114","volume":"76","author":"MW Jakowec","year":"2004","unstructured":"Jakowec MW, Nixon K, Hogg E, McNeill T, Petzinger GM. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway. J Neurosci Res. 2004;76(4):539\u201350.","journal-title":"J Neurosci Res"},{"issue":"3","key":"3965_CR50","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1006\/bbrc.1998.8986","volume":"248","author":"Y Mitsumoto","year":"1998","unstructured":"Mitsumoto Y, Watanabe A, Mori A, Koga N. Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL\/6 mice. Biochem Biophys Res Commun. 1998;248(3):660\u20133.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"3965_CR51","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1634\/stemcells.2005-0487","volume":"24","author":"X Shan","year":"2006","unstructured":"Shan X, Chi L, Bishop M, Luo C, Lien L, Zhang Z, Liu R. Enhanced de novo neurogenesis and dopaminergic neurogenesis in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson\u2019s disease-like mice. Stem Cells. 2006;24(5):1280\u20137.","journal-title":"Stem Cells"},{"issue":"13","key":"3965_CR52","doi-asserted-by":"publisher","first-page":"7925","DOI":"10.1073\/pnas.1131955100","volume":"100","author":"M Zhao","year":"2003","unstructured":"Zhao M, Momma S, Delfani K, Carl\u00e9n M, Cassidy RM, Johansson CB, et al. Evidence for neurogenesis in the adult mammalian substantia Nigra. Proc Natl Acad Sci U S A. 2003;100(13):7925\u201330.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"3965_CR53","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0969-9961(03)00108-6","volume":"14","author":"E Rousselet","year":"2003","unstructured":"Rousselet E, Joubert C, Callebert J, Parain K, Tremblay L, Orieux G, et al. Behavioral changes are not directly related to striatal monoamine levels, number of nigral neurons, or dose of parkinsonian toxin MPTP in mice. Neurobiol Dis. 2003;14(2):218\u201328.","journal-title":"Neurobiol Dis"},{"issue":"10","key":"3965_CR54","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/aps.2017.49","volume":"38","author":"QS Zhang","year":"2017","unstructured":"Zhang QS, Heng Y, Mou Z, Huang JY, Yuan YH, Chen NH. Reassessment of subacute MPTP-treated mice as animal model of Parkinson\u2019s disease. Acta Pharmacol Sin. 2017;38(10):1317\u201328.","journal-title":"Acta Pharmacol Sin"},{"issue":"Pt 7","key":"3965_CR55","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1093\/brain\/awu117","volume":"137","author":"AA Kehagia","year":"2014","unstructured":"Kehagia AA, Housden CR, Regenthal R, Barker RA, Muller U, Rowe J, et al. Targeting impulsivity in Parkinson\u2019s disease using atomoxetine. Brain. 2014;137(Pt 7):1986\u201397.","journal-title":"Brain"},{"issue":"1","key":"3965_CR56","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0301-0082(02)00011-4","volume":"67","author":"A Nieoullon","year":"2002","unstructured":"Nieoullon A. Dopamine and the regulation of cognition and attention. Prog Neurobiol. 2002;67(1):53\u201383.","journal-title":"Prog Neurobiol"},{"issue":"1","key":"3965_CR57","doi-asserted-by":"publisher","first-page":"e85747","DOI":"10.1371\/journal.pone.0085747","volume":"9","author":"C Nombela","year":"2014","unstructured":"Nombela C, Rittman T, Robbins TW, Rowe JB. Multiple modes of impulsivity in Parkinson\u2019s disease. PLoS ONE. 2014;9(1):e85747.","journal-title":"PLoS ONE"},{"issue":"7","key":"3965_CR58","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1111\/j.1742-4658.2012.08491.x","volume":"279","author":"F Blandini","year":"2012","unstructured":"Blandini F, Armentero MT. Animal models of Parkinson\u2019s disease. FEBS J. 2012;279(7):1156\u201366.","journal-title":"FEBS J"},{"key":"3965_CR59","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fnana.2014.00155","volume":"8","author":"J Blesa","year":"2014","unstructured":"Blesa J, Przedborski S. Parkinson\u2019s disease: animal models and dopaminergic cell vulnerability. Front Neuroanat. 2014;8:155.","journal-title":"Front Neuroanat"},{"issue":"1","key":"3965_CR60","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3233\/JPD-2011-11023","volume":"1","author":"GE Meredith","year":"2011","unstructured":"Meredith GE, Rademacher DJ. MPTP mouse models of Parkinson\u2019s disease: an update. J Parkinsons Dis. 2011;1(1):19\u201333.","journal-title":"J Parkinsons Dis"},{"key":"3965_CR61","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.neuroscience.2017.11.041","volume":"369","author":"D Huang","year":"2018","unstructured":"Huang D, Wang Z, Tong J, Wang M, Wang J, Xu J, et al. Long-term changes in the Nigrostriatal Pathway in the MPTP Mouse Model of Parkinson\u2019s Disease. Neuroscience. 2018;369:303\u201313.","journal-title":"Neuroscience"},{"issue":"1","key":"3965_CR62","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/BF03033338","volume":"1","author":"RK Schwarting","year":"1999","unstructured":"Schwarting RK, Sedelis M, Hofele K, Auburger GW, Huston JP. Strain-dependent recovery of open-field behavior and striatal dopamine deficiency in the mouse MPTP model of Parkinson\u2019s disease. Neurotox Res. 1999;1(1):41\u201356.","journal-title":"Neurotox Res"},{"issue":"1\u20132","key":"3965_CR63","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.physbeh.2009.04.021","volume":"98","author":"DW Luchtman","year":"2009","unstructured":"Luchtman DW, Shao D, Song C. Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson\u2019s disease. Physiol Behav. 2009;98(1\u20132):130\u20138.","journal-title":"Physiol Behav"},{"issue":"5","key":"3965_CR64","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1046\/j.1471-4159.2001.00183.x","volume":"76","author":"S Przedborski","year":"2001","unstructured":"Przedborski S, Jackson-Lewis V, Naini AB, Jakowec M, Petzinger G, Miller R, et al. The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety. J Neurochem. 2001;76(5):1265\u201374.","journal-title":"J Neurochem"},{"key":"3965_CR65","doi-asserted-by":"crossref","unstructured":"Roberton VH, Evans AE, Harrison DJ, Precious SV, Dunnett SB, Kelly CM et al. Is the adult mouse striatum a hostile host for neural transplant survival? Neuroreport. 2013;24(18):1010\u20131015.","DOI":"10.1097\/WNR.0000000000000066"},{"key":"3965_CR66","doi-asserted-by":"publisher","first-page":"860","DOI":"10.3389\/fneur.2018.00860","volume":"9","author":"P Troncoso-Escudero","year":"2018","unstructured":"Troncoso-Escudero P, Parra A, Nassif M, Vidal RL. Outside in: unraveling the role of Neuroinflammation in the progression of Parkinson\u2019s Disease. Front Neurol. 2018;9:860.","journal-title":"Front Neurol"},{"issue":"11","key":"3965_CR67","doi-asserted-by":"publisher","first-page":"26473","DOI":"10.3390\/ijms161125966","volume":"16","author":"FX Zuo","year":"2015","unstructured":"Zuo FX, Bao XJ, Sun XC, Wu J, Bai QR, Chen G, et al. Transplantation of human neural stem cells in a Parkinsonian Model exerts Neuroprotection via Regulation of the Host Microenvironment. Int J Mol Sci. 2015;16(11):26473\u201392.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"3965_CR68","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1002\/stem.2616","volume":"35","author":"F Zuo","year":"2017","unstructured":"Zuo F, Xiong F, Wang X, Li X, Wang R, Ge W, et al. Intrastriatal transplantation of human neural stem cells restores the impaired Subventricular Zone in Parkinsonian mice. Stem Cells. 2017;35(6):1519\u201331.","journal-title":"Stem Cells"},{"issue":"1","key":"3965_CR69","doi-asserted-by":"publisher","first-page":"e1376","DOI":"10.1371\/journal.pone.0001376","volume":"3","author":"EJ Benner","year":"2008","unstructured":"Benner EJ, Banerjee R, Reynolds AD, Sherman S, Pisarev VM, Tsiperson V, et al. Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons. PLoS ONE. 2008;3(1):e1376.","journal-title":"PLoS ONE"},{"issue":"1","key":"3965_CR70","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12974-023-02770-5","volume":"20","author":"Z Liu","year":"2023","unstructured":"Liu Z, Huang Y, Wang X, Li JY, Zhang C, Yang Y, et al. The cervical lymph node contributes to peripheral inflammation related to Parkinson\u2019s disease. J Neuroinflammation. 2023;20(1):93.","journal-title":"J Neuroinflammation"},{"issue":"10","key":"3965_CR71","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1369\/0022155414545334","volume":"62","author":"EZ da Silva","year":"2014","unstructured":"da Silva EZ, Jamur MC, Oliver C. Mast cell function: a new vision of an old cell. J Histochem Cytochem. 2014;62(10):698\u2013738.","journal-title":"J Histochem Cytochem"},{"issue":"1","key":"3965_CR72","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s11481-017-9766-1","volume":"13","author":"D Kempuraj","year":"2018","unstructured":"Kempuraj D, Selvakumar GP, Zaheer S, Thangavel R, Ahmed ME, Raikwar S, et al. Cross-talk between Glia, neurons and Mast Cells in Neuroinflammation Associated with Parkinson\u2019s Disease. J Neuroimmune Pharmacol. 2018;13(1):100\u201312.","journal-title":"J Neuroimmune Pharmacol"},{"key":"3965_CR73","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.bbi.2020.01.013","volume":"87","author":"GP Selvakumar","year":"2020","unstructured":"Selvakumar GP, Ahmed ME, Thangavel R, Kempuraj D, Dubova I, Raikwar SP, et al. A role for glia maturation factor dependent activation of mast cells and microglia in MPTP induced dopamine loss and behavioural deficits in mice. Brain Behav Immun. 2020;87:429\u201343.","journal-title":"Brain Behav Immun"},{"issue":"23","key":"3965_CR74","doi-asserted-by":"publisher","first-page":"13632","DOI":"10.1073\/pnas.2234031100","volume":"100","author":"CT Ekdahl","year":"2003","unstructured":"Ekdahl CT, Claasen JH, Bonde S, Kokaia Z, Lindvall O. Inflammation is detrimental for neurogenesis in adult brain. Proc Natl Acad Sci U S A. 2003;100(23):13632\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"3965_CR75","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.neuroscience.2007.11.036","volume":"151","author":"PM Aponso","year":"2008","unstructured":"Aponso PM, Faull RLM, Connor B. Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson\u2019s disease. Neuroscience. 2008;151(4):1142\u201353.","journal-title":"Neuroscience"},{"issue":"1","key":"3965_CR76","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s13287-021-02398-3","volume":"12","author":"T Mourtzi","year":"2021","unstructured":"Mourtzi T, Dimitrakopoulos D, Kakogiannis D, Salodimitris C, Botsakis K, Meri DK, et al. Characterization of substantia nigra neurogenesis in homeostasis and dopaminergic degeneration: beneficial effects of the microneurotrophin BNN-20. Stem Cell Res Ther. 2021;12(1):335.","journal-title":"Stem Cell Res Ther"},{"key":"3965_CR77","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.neuroscience.2017.03.045","volume":"352","author":"MQ Xie","year":"2017","unstructured":"Xie MQ, Chen ZC, Zhang P, Huang HJ, Wang TT, Ding YQ, et al. Newborn dopaminergic neurons are associated with the migration and differentiation of SVZ-derived neural progenitors in a 6-hydroxydopamin-injected mouse model. Neuroscience. 2017;352:64\u201378.","journal-title":"Neuroscience"},{"issue":"1","key":"3965_CR78","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.neurobiolaging.2008.03.002","volume":"31","author":"NM Ben Abdallah","year":"2010","unstructured":"Ben Abdallah NM, Slomianka L, Vyssotski AL, Lipp HP. Early age-related changes in adult hippocampal neurogenesis in C57 mice. Neurobiol Aging. 2010;31(1):151\u201361.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"3965_CR79","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1460-9568.2009.07061.x","volume":"31","author":"A Jab\u00e8s","year":"2010","unstructured":"Jab\u00e8s A, Lavenex PB, Amaral DG, Lavenex P. Quantitative analysis of postnatal neurogenesis and neuron number in the macaque monkey dentate gyrus. Eur J Neurosci. 2010;31(2):273\u201385.","journal-title":"Eur J Neurosci"},{"issue":"3","key":"3965_CR80","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1046\/j.1474-9728.2003.00046.x","volume":"2","author":"K Jin","year":"2003","unstructured":"Jin K, Sun Y, Xie L, Batteur S, Mao XO, Smelick C, et al. Neurogenesis and aging: FGF-2 and HB-EGF restore neurogenesis in hippocampus and subventricular zone of aged mice. Aging Cell. 2003;2(3):175\u201383.","journal-title":"Aging Cell"},{"issue":"6","key":"3965_CR81","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1523\/JNEUROSCI.16-06-02027.1996","volume":"16","author":"HG Kuhn","year":"1996","unstructured":"Kuhn HG, Dickinson-Anson H, Gage FH. Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. J Neurosci. 1996;16(6):2027\u201333.","journal-title":"J Neurosci"},{"key":"3965_CR82","doi-asserted-by":"crossref","unstructured":"Takamura N, Nakagawa S, Masuda T, Boku S, Kato A, Song N et al. The effect of dopamine on adult hippocampal neurogenesis. Prog Neuropsychopharmacol Biol Psychiatry. 2014;50:116\u201324.","DOI":"10.1016\/j.pnpbp.2013.12.011"},{"key":"3965_CR83","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3389\/fnmol.2016.00101","volume":"9","author":"T Zhang","year":"2016","unstructured":"Zhang T, Hong J, Di T, Chen L. MPTP impairs dopamine D1 receptor-mediated survival of newborn neurons in ventral Hippocampus to cause depressive-like behaviors in adult mice. Front Mol Neurosci. 2016;9:101.","journal-title":"Front Mol Neurosci"},{"issue":"Pt 10","key":"3965_CR84","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1093\/brain\/awn198","volume":"131","author":"S Pluchino","year":"2008","unstructured":"Pluchino S, Muzio L, Imitola J, Deleidi M, Alfaro-Cervello C, Salani G, et al. Persistent inflammation alters the function of the endogenous brain stem cell compartment. Brain. 2008;131(Pt 10):2564\u201378.","journal-title":"Brain"},{"key":"3965_CR85","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40035-018-0109-9","volume":"7","author":"B Shohayeb","year":"2018","unstructured":"Shohayeb B, Diab M, Ahmed M, Ng DCH. Factors that influence adult neurogenesis as potential therapy. Transl Neurodegener. 2018;7:4\u2013018. eCollection 2018.","journal-title":"Transl Neurodegener"},{"issue":"9","key":"3965_CR86","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1523\/JNEUROSCI.3574-07.2008","volume":"28","author":"P Yang","year":"2008","unstructured":"Yang P, Arnold SA, Habas A, Hetman M, Hagg T. Ciliary neurotrophic factor mediates dopamine D2 receptor-induced CNS neurogenesis in adult mice. J Neurosci. 2008;28(9):2231\u201341.","journal-title":"J Neurosci"},{"issue":"2","key":"3965_CR87","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.pneurobio.2012.06.005","volume":"98","author":"KJ Doorn","year":"2012","unstructured":"Doorn KJ, Lucassen PJ, Boddeke HW, Prins M, Berendse HW, Drukarch B, et al. Emerging roles of microglial activation and non-motor symptoms in Parkinson\u2019s disease. Prog Neurobiol. 2012;98(2):222\u201338.","journal-title":"Prog Neurobiol"},{"key":"3965_CR88","doi-asserted-by":"crossref","unstructured":"Doorn KJ, Moors T, Drukarch B, van de Berg WD, Lucassen PJ, van Dam AM. Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson\u2019s disease patients. Acta Neuropathol Commun. 2014;2:90\u2013014.","DOI":"10.1186\/PREACCEPT-2025829283135633"},{"issue":"1","key":"3965_CR89","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s40478-020-01083-5","volume":"8","author":"A Kouli","year":"2020","unstructured":"Kouli A, Camacho M, Allinson K, Williams-Gray CH. Neuroinflammation and protein pathology in Parkinson\u2019s disease dementia. Acta Neuropathol Commun. 2020;8(1):211\u2013020. -01083-5.","journal-title":"Acta Neuropathol Commun"},{"issue":"2","key":"3965_CR90","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4103\/2347-8659.139719","volume":"1","author":"IB Hovens","year":"2014","unstructured":"Hovens IB, Nyakas C, Schoemaker RG. A novel method for evaluating microglial activation using ionized calcium-binding adapter protein-1 staining: cell body to cell size ratio. Neuroimmunol Neuroinflammation. 2014;1(2):82\u20138.","journal-title":"Neuroimmunol Neuroinflammation"},{"key":"3965_CR91","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.brainres.2009.02.031","volume":"1266","author":"LA Shapiro","year":"2009","unstructured":"Shapiro LA, Perez ZD, Foresti ML, Arisi GM, Ribak CE. Morphological and ultrastructural features of Iba1-immunolabeled microglial cells in the hippocampal dentate gyrus. Brain Res. 2009;1266:29\u201336.","journal-title":"Brain Res"},{"issue":"2","key":"3965_CR92","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.expneurol.2005.12.035","volume":"199","author":"A Wennersten","year":"2006","unstructured":"Wennersten A, Holmin S, Al Nimer F, Meijer X, Wahlberg LU, Mathiesen T. Sustained survival of xenografted human neural stem\/progenitor cells in experimental brain trauma despite discontinuation of immunosuppression. Exp Neurol. 2006;199(2):339\u201347.","journal-title":"Exp Neurol"},{"issue":"1","key":"3965_CR93","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/npp.2013.237","volume":"39","author":"RY Tam","year":"2014","unstructured":"Tam RY, Fuehrmann T, Mitrousis N, Shoichet MS. Regenerative therapies for central nervous system diseases: a biomaterials approach. Neuropsychopharmacology. 2014;39(1):169\u201388.","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"3965_CR94","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.3390\/ijms11082875","volume":"11","author":"T Falk","year":"2010","unstructured":"Falk T, Gonzalez RT, Sherman SJ. The Yin and Yang of VEGF and PEDF: multifaceted neurotrophic factors and their potential in the treatment of Parkinson\u2019s Disease. Int J Mol Sci. 2010;11(8):2875\u2013900.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"3965_CR95","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1227\/00006123-199510000-00018","volume":"37","author":"T Tsukahara","year":"1995","unstructured":"Tsukahara T, Takeda M, Shimohama S, Ohara O, Hashimoto N. Effects of brain-derived neurotrophic factor on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in monkeys. Neurosurgery. 1995;37(4):733\u20139. discussion 739\u2009\u2013\u200941.","journal-title":"Neurosurgery"},{"key":"3965_CR96","doi-asserted-by":"crossref","unstructured":"Hirsch MA, van Wegen EEH, Newman MA, Heyn PC. Exercise-induced increase in brain-derived neurotrophic factor in human Parkinson\u2019s disease: a systematic review and meta-analysis. Transl Neurodegener. 2018;7:7-018-0112-1. eCollection 2018.","DOI":"10.1186\/s40035-018-0112-1"},{"key":"3965_CR97","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.neuroscience.2013.01.060","volume":"237","author":"CC Real","year":"2013","unstructured":"Real CC, Ferreira AF, Chaves-Kirsten GP, Torrao AS, Pires RS, Britto LR. BDNF receptor blockade hinders the beneficial effects of exercise in a rat model of Parkinson\u2019s disease. Neuroscience. 2013;237:118\u201329.","journal-title":"Neuroscience"},{"issue":"1\u20133","key":"3965_CR98","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ejphar.2013.04.058","volume":"719","author":"SA van den Berge","year":"2013","unstructured":"van den Berge SA, van Strien ME, Hol EM. Resident adult neural stem cells in Parkinson\u2019s disease\u2013the brain\u2019s own repair system? Eur J Pharmacol. 2013;719(1\u20133):117\u201327.","journal-title":"Eur J Pharmacol"},{"issue":"10","key":"3965_CR99","doi-asserted-by":"publisher","first-page":"e0140566","DOI":"10.1371\/journal.pone.0140566","volume":"10","author":"AD Thome","year":"2015","unstructured":"Thome AD, Standaert DG, Harms AS. Fractalkine Signaling regulates the inflammatory response in an alpha-synuclein model of Parkinson Disease. PLoS ONE. 2015;10(10):e0140566.","journal-title":"PLoS ONE"},{"issue":"20","key":"3965_CR100","doi-asserted-by":"publisher","first-page":"8108","DOI":"10.1523\/JNEUROSCI.21-20-08108.2001","volume":"21","author":"P Akerud","year":"2001","unstructured":"Akerud P, Canals JM, Snyder EY, Arenas E. Neuroprotection through delivery of glial cell line-derived neurotrophic factor by neural stem cells in a mouse model of Parkinson\u2019s disease. J Neurosci. 2001;21(20):8108\u201318.","journal-title":"J Neurosci"},{"issue":"1\u20132","key":"3965_CR101","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0006-8993(00)03270-4","volume":"896","author":"CM Fox","year":"2001","unstructured":"Fox CM, Gash DM, Smoot MK, Cass WA. Neuroprotective effects of GDNF against 6-OHDA in young and aged rats. Brain Res. 2001;896(1\u20132):56\u201363.","journal-title":"Brain Res"},{"issue":"9","key":"3965_CR102","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1177\/0963689717721202","volume":"26","author":"A Perez-Bouza","year":"2017","unstructured":"Perez-Bouza A, Di Santo S, Seiler S, Meyer M, Andereggen L, Huber A, et al. Simultaneous transplantation of fetal ventral mesencephalic tissue and encapsulated genetically modified cells releasing GDNF in a Hemi-Parkinsonian Rat Model of Parkinson\u2019s Disease. Cell Transpl. 2017;26(9):1572\u201381.","journal-title":"Cell Transpl"},{"issue":"1","key":"3965_CR103","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00441-020-03253-2","volume":"382","author":"T Brigadski","year":"2020","unstructured":"Brigadski T, Le\u00dfmann V. The physiology of regulated BDNF release. Cell Tissue Res. 2020;382(1):15\u201345.","journal-title":"Cell Tissue Res"},{"issue":"6","key":"3965_CR104","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41419-020-2615-9","volume":"11","author":"S Fern\u00e1ndez-Garc\u00eda","year":"2020","unstructured":"Fern\u00e1ndez-Garc\u00eda S, Sancho-Balsells A, Longueville S, Herv\u00e9 D, Gruart A, Delgado-Garc\u00eda JM, et al. Astrocytic BDNF and TrkB regulate severity and neuronal activity in mouse models of temporal lobe epilepsy. Cell Death Dis. 2020;11(6):411\u2013020.","journal-title":"Cell Death Dis"},{"issue":"37","key":"3965_CR105","doi-asserted-by":"publisher","first-page":"12547","DOI":"10.1523\/JNEUROSCI.0324-14.2014","volume":"34","author":"D Bambah-Mukku","year":"2014","unstructured":"Bambah-Mukku D, Travaglia A, Chen DY, Pollonini G, Alberini CM. A positive autoregulatory BDNF feedback loop via C\/EBP\u03b2 mediates hippocampal memory consolidation. J Neurosci. 2014;34(37):12547\u201359.","journal-title":"J Neurosci"},{"issue":"3","key":"3965_CR106","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s12031-018-1124-0","volume":"68","author":"C Jiang","year":"2019","unstructured":"Jiang C, Lin WJ, Salton SR. Role of a VGF\/BDNF\/TrkB Autoregulatory Feedback Loop in Rapid-acting antidepressant efficacy. J Mol Neurosci. 2019;68(3):504\u20139.","journal-title":"J Mol Neurosci"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-024-03965-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-024-03965-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-024-03965-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T19:03:32Z","timestamp":1728500612000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-024-03965-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,9]]},"references-count":106,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3965"],"URL":"https:\/\/doi.org\/10.1186\/s13287-024-03965-0","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,9]]},"assertion":[{"value":"23 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal work and use of hNSCs were approved by the Universidad Aut\u00f3noma de Madrid (CEI 62-1077-A079; 06\/03\/2015) and the Comunidad de Madrid (PROEX149\/15; 29\/05\/2015) Research Ethics Committees, both with project title \u00a8Desarrollo hacia la cl\u00ednica del trasplante de c\u00e9lulas troncales neurales humanas para la enfermedad de Parkinson\u00a8.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that artificial intelligence is not used in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Artificial intelligence"}}],"article-number":"356"}}